1. Home
  2. Analysis
  3. Pyridoxal-phosphate
  4. Zoledronic-acid

Pyridoxal phosphate and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 2 people who take Pyridoxal phosphate and Zoledronic acid. Common interactions include colorectal cancer metastatic among females, and pyrexia among males.

The phase IV clinical study analyzes what interactions people who take Pyridoxal phosphate and Zoledronic acid have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

2 people who take Pyridoxal phosphate and Zoledronic acid together, and have interactions are studied.

What is Pyridoxal phosphate?

Pyridoxal phosphate has active ingredients of pyridoxine (vitamin b6). Currently, eHealthMe is studying from 625 Pyridoxal phosphate users.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. Currently, eHealthMe is studying from 25,642 Zoledronic acid users.

Number of Pyridoxal phosphate and Zoledronic acid reports submitted per year:

Pyridoxal phosphate and Zoledronic acid drug interactions.

Common Pyridoxal Phosphate and Zoledronic Acid drug interactions by gender *:

female:

  1. Colorectal cancer metastatic
  2. Febrile neutropenia
  3. Malignant neoplasm progression
  4. Neuropathy peripheral
  5. Skin disorder

male:

  1. Pyrexia
  2. Cerebral infarction
  3. Lymphadenopathy
  4. Malaise
  5. Multiple sclerosis
  6. Osteitis
  7. Osteonecrosis of jaw
  8. Pleural effusion
  9. Swelling face
  10. Demyelination

Common Pyridoxal Phosphate and Zoledronic Acid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pyrexia
  2. Cerebral infarction
  3. Lymphadenopathy
  4. Malaise
  5. Multiple sclerosis
  6. Osteitis
  7. Osteonecrosis of jaw
  8. Pleural effusion
  9. Swelling face
  10. Colorectal cancer metastatic

* Approximation only. Some reports may have incomplete information.

Do you take Pyridoxal phosphate and Zoledronic acid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Pyridoxal phosphate drug interactions:

Browse interactions between Pyridoxal phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zoledronic acid drug interactions:

Browse interactions between Zoledronic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pyridoxine (vitamin b6) and zoledronic acid (the active ingredients of Pyridoxal phosphate and Zoledronic acid, respectively), and Pyridoxal phosphate and Zoledronic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pyridoxal phosphate and Zoledronic acid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.